WuXi Biologics (Cayman) Inc. (HKG: 2269)
Hong Kong
· Delayed Price · Currency is HKD
18.46
-0.24 (-1.28%)
Jan 21, 2025, 1:01 PM HKT
WuXi Biologics Employees
WuXi Biologics had 12,740 employees as of December 31, 2023. The number of employees increased by 367 or 2.97% compared to the previous year.
Employees
12,740
Change (1Y)
367
Growth (1Y)
2.97%
Revenue / Employee
1.48M HKD
Profits / Employee
227.44K HKD
Market Cap
76.61B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 10,600 |
Hansoh Pharmaceutical Group Company | 9,123 |
JD Health International | 3,118 |
Sinopharm Group | 115,959 |
Alibaba Health Information Technology | 1,435 |
Akeso | 2,778 |
Sino Biopharmaceutical | 25,806 |
Innovent Biologics | 4,872 |
WuXi Biologics News
- 14 days ago - WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million - The Wall Street Journal
- 14 days ago - WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million - WSJ
- 14 days ago - WuXi Bio to Sell Vaccine Facility to Merck for $500 Million - BNN Bloomberg
- 14 days ago - WuXi Biologics Announces Strategic Agreement with Candid Therapeutics - GuruFocus
- 14 days ago - Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-cell Engager - Business Wire
- 14 days ago - WuXi Biologics Announces Agreement with Candid Therapeutics on Trispecific T-cell Engager - PRNewsWire
- 14 days ago - China’s WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom - South China Morning Post
- 14 days ago - Merck to buy vaccine plant from WuXi Biologics: report - Seeking Alpha